Acrivon Therapeutics | EFFECT:其他
04/30 18:11
Acrivon Therapeutics | ARS:年度報告
04/26 20:38
Acrivon Therapeutics | DEFA14A:其他
04/26 20:38
Acrivon Therapeutics | DEF 14A:股東委託書決議
04/26 20:33
Acrivon Therapeutics | 8-K:重大事件
04/25 04:06
Acrivon Therapeutics | 4:持股變動聲明-高管 Miller Mary
04/20 04:15
Acrivon Therapeutics | S-3:特定交易註冊聲明
04/18 04:41
Acrivon Therapeutics | 4:持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.
04/16 04:20
Acrivon Therapeutics | 4:持股變動聲明-股東 PERCEPTIVE ADVISORS LLC
04/15 20:58
Acrivon Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%)等
04/15 20:23
Acrivon Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%)等
04/12 04:22
Acrivon Therapeutics | 8-K:重大事件
04/09 19:09
Acrivon Therapeutics | S-8:員工福利計劃證券登記
03/29 21:07
Acrivon Therapeutics | 8-K:Acrivon Therapeutics公佈2023年第四季度和全年財務業績和業務亮點
03/28 20:04
Acrivon Therapeutics | 10-K:年度報表
03/28 19:39
Acrivon Therapeutics | 4:持股變動聲明-董事 Palani Santhosh
03/07 05:36
Acrivon Therapeutics | 3:首次持股聲明-董事 Palani Santhosh
03/07 05:31
Acrivon Therapeutics | 8-K:重大事件
03/04 21:20
Acrivon Therapeutics | 4:持股變動聲明-高管 Masson Kristina
02/17 06:19
Acrivon Therapeutics | 4:持股變動聲明-高管 Miller Mary
02/17 06:18
暫無數據
暫無數據